Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma. [ATAC-Seq, cell line]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 18 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- OsteosarcomaThis series is part of our curated briefing on it.
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE308957_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1333485 and SRA study SRP625633. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9256765 os833_siNeg_1 os833_siNeg
- GSM9256766 os833_siNeg_2 os833_siNeg
- GSM9256767 os833_siNeg_3 os833_siNeg
- GSM9256768 os833_siRUNX2_1 os833_siRUNX2
- GSM9256769 os833_siRUNX2_2 os833_siRUNX2
- GSM9256770 os833_siRUNX2_3 os833_siRUNX2
- GSM9256771 os833_siSP7_1 os833_siSP7
- GSM9256772 os833_siSP7_2 os833_siSP7
- GSM9256773 os833_siSP7_3 os833_siSP7
- GSM9256774 OS742_siNeg_1 OS742_siNeg
- GSM9256775 OS742_siNeg_2 OS742_siNeg
- GSM9256776 OS742_siNeg_3 OS742_siNeg
- GSM9256777 OS742_siRUNX2_1 OS742_siRUNX2
- GSM9256778 OS742_siRUNX2_2 OS742_siRUNX2
- GSM9256779 OS742_siRUNX2_3 OS742_siRUNX2
- GSM9256780 OS742_siSP7_1 OS742_siSP7
- GSM9256781 OS742_siSP7_2 OS742_siSP7
- GSM9256782 OS742_siSP7_3 OS742_siSP7
- GSE270502 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [ATAC-seq] 87 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs, atac-seq
- GSE309031 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [CUT&Run] 85 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE270506 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma. 279 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE270503 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [Cut&Run] 56 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE270505 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [RNA-seq] 19 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE270504 Epigenetic heterogeneity and state-specific transcriptional programs determine differential drug response in osteosarcoma [snRNAseq + snATACseq] 4 samples same disease briefing · shares state-specific, heterogeneity, differential, osteosarcoma, epigenetic, determine, programs
- GSE307240 Epigenetic and transcriptional heterogeneity define osteosarcoma subtypes and establish targetable vulnerabilities [multiomics] 10 samples same disease briefing · shares heterogeneity, osteosarcoma, epigenetic
- GSE270231 Aberrant activation of wound healing programs within the metastatic niche facilitates lung colonization by osteosarcoma cells 7 samples same disease briefing · shares osteosarcoma, programs
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.